These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7181758)

  • 1. Timolol and dipivalyl epinephrine combination therapy.
    McGuinness R; Frumar KD
    Aust J Ophthalmol; 1982 Aug; 10(3):179-82. PubMed ID: 7181758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experience with dipivalyl epinephrine. Its effectiveness, alone or in combination, and its side effects.
    Cebon L; West RH; Gillies WE
    Aust J Ophthalmol; 1983 Aug; 11(3):159-61. PubMed ID: 6639507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of timolol and dipivalyl-epinephrine in the treatment of the elevated intraocular pressure (author's transl)].
    Ober M; Scharrer A
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1980; 213(4):273-81. PubMed ID: 6906160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drop attack in glaucoma. The Melbourne experience with topical miotics, adrenergic and neuronal blocking drops.
    West RH; Cebon L; Gillies WE
    Aust J Ophthalmol; 1983 Aug; 11(3):149-53. PubMed ID: 6639505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of topical brinzolamide 1% and dorzolamide 2% eye drops given twice daily in addition to timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
    Michaud JE; Friren B;
    Am J Ophthalmol; 2001 Aug; 132(2):235-43. PubMed ID: 11476685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timolol and epinephrine: long-term evaluation of concurrent administration.
    Korey MS; Hodapp E; Kass MA; Goldberg I; Gordon M; Becker B
    Arch Ophthalmol; 1982 May; 100(5):742-5. PubMed ID: 7044351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of the intraocular pressure lowering effect of timolol and dipivalyl epinephrine.
    Frumar KD; McGuinness R
    Aust J Ophthalmol; 1982 May; 10(2):121-3. PubMed ID: 7049141
    [No Abstract]   [Full Text] [Related]  

  • 8. Additive effect of epinephrine to timolol therapy in primary open angle glaucoma.
    Cyrlin MN; Thomas JV; Epstein DL
    Arch Ophthalmol; 1982 Mar; 100(3):414-8. PubMed ID: 7065957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenergic and adrenolytic effects on intraocular pressure.
    Drance SM; Douglas GR; Wijsman KJ; Schulzer M
    Graefes Arch Clin Exp Ophthalmol; 1991; 229(1):50-1. PubMed ID: 2004722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of 0.1% dipivalyl epinephrine and 1% epinephrine in patients with glaucoma or ocular hypertension].
    Shao H; Sun XY; Bai FG
    Zhonghua Yan Ke Za Zhi; 1994 Mar; 30(2):104-7. PubMed ID: 8001439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial administration of adrenergic antagonist and agonist ("pulsatile therapy") reduces the incidence of long-term drift to timolol in humans.
    Gandolfi SA; Vecchi M
    Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):684-8. PubMed ID: 8595970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined timolol and epinephrine therapy for open angle glaucoma.
    Knupp JA; Shields MB; Mandell AI; Hurvitz L; Spaeth GL
    Surv Ophthalmol; 1983 Dec; 28 Suppl():280-5. PubMed ID: 6665707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of travoprost as adjunctive therapy in patients with uncontrolled intraocular pressure while using timolol 0.5%.
    Orengo-Nania S; Landry T; Von Tress M; Silver LH; Weiner A; Davis AA;
    Am J Ophthalmol; 2001 Dec; 132(6):860-8. PubMed ID: 11730649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of the additive effect of timolol and epinephrine in lowering intraocular pressure.
    Thomas JV; Epstein DL
    Br J Ophthalmol; 1981 Sep; 65(9):596-602. PubMed ID: 7028085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of the combination of l-moprolol and dipivefrin in reducing the intraocular pressure in primary open-angle glaucoma or in ocular hypertension.
    Rossetti L; Barbieri P; Velati P; Bujtar E; Orzalesi N
    Graefes Arch Clin Exp Ophthalmol; 1994 Nov; 232(11):670-4. PubMed ID: 7843592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timolol and epinephrine in primary open angle glaucoma. Transient additive effect.
    Thomas JV; Epstein DL
    Arch Ophthalmol; 1981 Jan; 99(1):91-5. PubMed ID: 7006581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timolol. Hypotensive effect, used alone and in combination for treatment of increased intraocular pressure.
    Nielsen NV
    Acta Ophthalmol (Copenh); 1978; 56(4):504-9. PubMed ID: 32733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension.
    Netland PA; Landry T; Sullivan EK; Andrew R; Silver L; Weiner A; Mallick S; Dickerson J; Bergamini MV; Robertson SM; Davis AA;
    Am J Ophthalmol; 2001 Oct; 132(4):472-84. PubMed ID: 11589866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized trial comparing the dorzolamide-timolol combination given twice daily to monotherapy with timolol and dorzolamide. Dorzolamide-Timolol Study Group.
    Boyle JE; Ghosh K; Gieser DK; Adamsons IA
    Ophthalmology; 1998 Oct; 105(10):1945-51. PubMed ID: 9787368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of the intraocular pressure lowering effect of timolol and dipivalyl epinephrine.
    Frumar KD; McGuinness R
    Trans Ophthalmol Soc N Z; 1981; 33():27-9. PubMed ID: 7020221
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.